News Article | December 2, 2016
The global Medical Education Market has a handful of players such as Apollo Hospitals, TACT Academy for Clinical Training, Zimmer Biomet Holdings, Inc. (Zimmer Institute), Olympus Corporation, Gundersen Health System, GE Healthcare, and Medical Training College. Transparency Market Research identifies Apollo Hospitals as the leading contributor to the growth of the overall market owing to its extensive course portfolio, strong market penetration in countries in Asia Pacific, and vast scope for practical hospital experience. “Geographical expansion in several developing countries has been Apollo Hospitals’ leading growth strategy, in addition to the acquisition of smaller local players,” finds the lead author of the TMR study. In July 2016, Apollo Hospitals Group signed MoUs with Kenyatta National Hospital and Airtel Kenya to not just focus on capacity building in the Kenyan healthcare sector but to also conduct educational lectures and training programs in the country. In the same month, the company signed an agreement with Hainan Ecological Smart City Group in China to develop a highly integrated modern healthcare service facility in the Hainan province, which is likely to lend nursing, medical, and paramedical colleges in the island city tremendous support. Advantages of Online Training over Traditional Modes of Education a Driving Factor The demand for medical education is primarily driven by the growing preference for online education. “Online education is a highly lucrative investment avenue,” a TMR analyst observes. “The exposure to modern technologies around the world and the increasing penetration of the internet has greatly fueled the preference of students for online education.” Moreover, online training presents several advantages over traditional modes of education, including variation in training and educational programs, lower cost, comfortable and flexible learning programs, and opportunities for improved technical skills. In line with this growing trend, TMR predicts that the emergence of e-learning markets in several developing countries will be a major opportunity for players in the medical education market. Get Exclusive Sample Paper of this Research - http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=517 The cost of higher education, especially in developed countries, continues to pose a key challenge for low-income students. “Medical education is one of the most expensive fields and the tuition fee for classroom courses as well as on-campus training is extremely high. This acts as a major barrier for the medical education market,” the author of the study says. In addition to this, the declining preference for distance education in medicine and paramedical training is likely to restrict the growth of the medical education market to an extent. Expanding at a 4.3% CAGR over the course of the forecast period, the global medical education market is poised to rise from a value of US$25.9 bn in 2015 to US$38.4 bn by 2024. By mode of education, the medical education market is led by on-campus training. Changing student preferences will restrict the demand for distance training by 2024, TMR predicts. However, online training is fast emerging as a lucrative mode of medical education and this segment is likely to register the highest CAGR of 7.29% from 2016 to 2024. By type of training, the demand for cardiothoracic training has surpassed the rest, while training in radiology presents the highest scope for growth. By geography, North America led the overall medical education market with Asia Pacific as the most rapidly expanding regional segment through the forecast period. This review is based on the findings of a TMR report titled “Medical Education Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024.” Speak with Research Expert, and know more about Emerging trends in Medical Education Market - http://www.transparencymarketresearch.com/sample/sample.php?flag=ASK&rep_id=517 Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge. Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
News Article | December 7, 2016
— Driven by the thriving ecosystem, research estimates that the mHealth market will account for over $23 Billion in 2017 alone. Despite barriers relating to regulation, patient acceptance and privacy concerns, Research estimates further growth at a CAGR of more than 35% over the next three years. Complete report spreads across 424 pages is available at http://www.reportsnreports.com/reports/747323-the-mhealth-mobile-healthcare-ecosystem-2017-2030-opportunities-challenges-strategies-forecasts.html . While the use of mHealth devices and apps is already widespread in clinical trials, pharmaceutical giants are now setting their sights on connected drug delivery platforms that will automatically detect and log patients’ medication use to improve adherence. Research estimates that mHealth centric wearable devices will account for over 60 Million unit shipments by the end of 2017. In order to gain valuable insights from the data generated by these devices, healthcare service providers and other stakeholders are increasingly investing in Big Data and analytics technology. mHealth has the potential to dramatically reduce the costs of healthcare operations, while improving the quality of healthcare. Research estimates that by the end of 2017, mHealth could represent up to $370 Billion in annual healthcare cost savings worldwide. With more than 7 Billion mobile network subscriptions worldwide, the mobile communications sector is rapidly gaining traction from a diverse range of vertical sectors. Healthcare is no exception to this trend. As healthcare service providers seek to maximize their patient outreach while minimizing costs, many view mobile healthcare (or mHealth) as the solution to improve healthcare cost–efficiency. mHealth refers to the usage of mobile communications technology and devices to enhance access to healthcare information, improve distribution of routine and emergency health services, and provide diagnostic services. Order a Copy of Report at http://www.reportsnreports.com/purchase.aspx?name=747323. Mobile operators also view mHealth as a lucrative opportunity for the monetization of their mobile connectivity services as a growing proportion of their subscribers adopt healthcare centric wearables. Given that most operators have established themselves as reputable consumer brands, they are also eyeing at opportunities to offer services beyond simple connectivity. Many operators already offer branded or co-branded end-to-end mHealth solutions to their customer bases. In addition, mHealth offers a multitude to opportunities to the pharmaceutical industry ranging from enhanced R&D activities and medication adherence to securing the supply chain and combating counterfeit drugs. Topics Covered • The scope and implementation of mHealth across the globe • mHealth technology • Market drivers and key benefits of mHealth • Challenges and inhibitors to the mHealth ecosystem • mHealth standardization and regulatory initiatives • mHealth opportunities, use cases and applications • mHealth deployment case studies • Value chain analysis of the mHealth ecosystem and the recognition of key players in each segment of the value chain • mHealth industry roadmap: 2017 – 2030 • Key trends in the mHealth ecosystem; mHealth regulation, security, adoption of cloud based mHealth services, alliances for ecosystem fortification, and the impact of LTE/5G deployments • The role of IoT and wearable technology in the mHealth ecosystem • Profiles and strategies of over 230 leading ecosystem players • Strategic recommendations for mobile operators, enabling technology providers, mHealth device OEMs, application developers, healthcare service providers and pharmaceutical companies • In-depth analysis for 5 individual submarkets and their associated mHealth application use cases: • Pharmaceutical Applications • Medical Information & Healthcare Management • Healthcare & Fitness • Remote Consultation/Diagnostic Services • IoT, Wearable Technology, Sensor & Monitoring Applications • Historical revenue figures and forecasts till 203 Forecast Segmentation Market forecasts and historical revenue figures are provided for each of the following 5 submarkets and their 23 use case categories: Pharmaceutical Applications • Safety Data Collection • Consumer Education • Medical Education • Post–Market Monitoring • Drug Authentication • Social Media • Patient Compliance & Retention: Clinical Trials IoT, Wearable Technology, Sensor & Monitoring Applications • Health and Wellness Monitoring • Disease Surveillance/Remote Monitoring • Diagnostic Tools • Technical Logistics • Revenue is also split by ecosystem player: Additional forecasts are provided for the following IoT connections for mHealth applications; mHealth centric wearable device shipments; Mobile video calling users; Annual throughput of mobile network data traffic; Smartphone, feature phone, tablet, desktop PC and notebook shipments; Mobile network subscriptions by region; Cost saving potential of mHealth by region; Big Data & analytics technology investments in the healthcare sector List of Companies Mentioned are 270 Vision, 3L Labs, 3M, 4DForce, 4iii Innovations, Abbott Laboratories, Accenture, AdhereTech, Adherium, Adidas, AeroScout, Aerotel Medical Systems, Aetna, Agfa Healthcare, Agfa-Gevaert Group, AiRISTA, AirStrip Technologies, Alego Health, AliveCor, AllScripts Healthcare, Alphabet, Altran Group, AMD Global Telemedicine, Amiigo, Anthem, Apollo Hospitals, Appirio, Apple and more. For more information, please visit http://www.reportsnreports.com/reports/747323-the-mhealth-mobile-healthcare-ecosystem-2017-2030-opportunities-challenges-strategies-forecasts.html
News Article | November 17, 2016
Medical tourism is one of the most dynamically growing industries today. Considered to be the direct impact of globalisation of healthcare, medical tourism certainly exhibits strong growth potential globally. However, based on FMI’s research, the market of medical tourism is expected to concentrate within most of the emerging economies of the world. As developing nations are increasingly heading toward technological advancement and quality services in the medical and healthcare sector, the global medical tourism market is anticipated to witness robust growth over 2014-2020, predominantly in Asian countries. The top treatments people travel abroad for, include cancer therapy, cardiovascular surgeries, orthopaedic treatments, dentistry, cosmetic surgeries, reproductive treatments, weight loss therapies, health screenings, and medical tests and scans. In severe cases, a sizeable patient population also seeks second opinion from specialist doctors out of their countries. High treatment costs and lengthy waiting times for medical procedures, being the two major factors in driving medical tourism, are also supported by easier and cheaper international travel. While the U.K.’s population prefers to travel abroad for bypassing long waits, patients from the U.S. travel outside for availing of treatments at cheaper costs. Medical excellence along with international accreditation are the key factors fuelling a majority of international patient flow, eventually boosting international medical tourism. Currently, over 600 medical departments and hospitals all over the globe are accredited by the U.S. Joint Commission International (JCI). The number of accredited facilities is projected to increase almost by 20% each year. This is another important driver associated with the market growth. Developing countries, with ever-evolving innovation and demonstrable achievements in medical research are estimated to accelerate the approaching medical tourist flow over the forecast period. Growing healthcare investments by various government and private sectors are also anticipated to further bolster the market growth. However, medical tourists are highly prone to a wide variety of health risks after they return. The conditions may include TB, paratyphoid, amoebic dysentery, deep vein thrombosis, and more; usually caused due to poor post-operative care and inadequate rest. This could affect the market to some extent. Stringent documentation processes, issues related to visa approval, and limited insurance coverage are reportedly some of the most deterring factors for the global market. FMI’s research on the global medical tourism market offers a six-year forecast, segmenting the market on the basis of type of medical treatment and geography. On the basis of the type of treatment, the market is segmented into cosmetic treatment, cardiovascular treatment, fertility treatment, dental treatment, orthopaedic treatment, and other general treatments. On the basis of geography, the market is segmented into Asia pacific, Eastern Europe, Western Europe, North America, and South America. Some of the prominent medical tourism centres across the globe include Thailand, India, South Korea, Taiwan, Costa Rica, Israel, Brazil, Turkey, the Philippines, Dubai, Singapore, Malaysia, Mexico, Poland, Canada, and the U.S. According to Patients Beyond Borders, the global medical tourism market is currently growing at an impressive rate between 15% and 25%, and the flow of patients seeking cross-border treatment options will be the highest in Mexico. South and Southeast Asia are expected to dominate the global market in the near future. Based on MTA’s recently released Medical Tourism Index, there are 41 countries participating in the global medical tourism market. While India broadly secures #1, Israel ranks #1 in the quality of services and facilities. India is renowned for specialist cardiac surgeries, while Singapore is a popular medical tourism destination owing to the expertise in complicated surgical procedures. Thailand has been a popular destination for medical tourism and millions of patients have travelled to Thailand since 2006. It is also the top cosmetic surgery centre globally. Malaysia offers state-of-the-art medical infrastructure and treatments by highly skilled medical professionals, making it another sought after centre among medical tourists. With economically affordable treatment options and favourable government initiatives, Malaysia is anticipated to acquire one of the top market positions in the global medical tourism market, during the forecast period. Some of the top key players in the medical tourism industry include Asian Heart Institute (India), Apollo Hospitals (India), Prince Court Medical Centre (Malaysia), Gleneagles Hospital (Singapore), Min-Sheng General Hospital (Taiwan), Samitivej Sukhumvit Hospital (Bangkok), Raffles Medical Group (Singapore), Clemenceau Medical Centre (Lebanon), Bangkok Hospital (Thailand), Bumrungrad International Hospital (Thailand), Fortis Healthcare Ltd. (India), Wooridul Spine Hospital (Korea), KPJ Healthcare Berhad (Malaysia), Anadolu Medical Centre (Turkey), and Asklepios Klinik Barmbek (Germany). While these players rank amongst they compete on the basis of exceptional service quality, optimum patient comfort, and relatively reasonable costs for various treatments. Several facilities are also undergoing mergers, acquisitions, affiliations, and joint ventures for delivering enhanced medical care, thereby strengthening their market positions. A few prominent examples of highly productive collaborations include the collaboration between Bumrungrad International Hospital (Bangkok) and IBM Watson for better cancer care, and the collaboration of Anadolu Medical Centre (Turkey) with Johns Hopkins Medicine (U.S.).
News Article | November 29, 2016
The global medical tourism market is led by some of the key companies including Apollo Hospitals (India), Prince Court Medical Center, and Bumrungrad International Hospital (Thailand). Key companies are concentrating on sophisticating some of the medical tourism services including neurosurgery, cardiac surgery, dental care, cosmetic surgeries, and orthopedics. Over the past years, the global medical tourism market has growth at a considerable rate owing to the rising medical infrastructure and the availability of medical devices. Globalization of health care services has largely propelled the global medical tourism market. Transparency Market Research Report (TMR), in its new report, states that changing trends in globalization of the healthcare industry have assisted people to avail affordable medical services. The global medical tourism market is expected to reach US$32.5 bn by 2019. Based on geography, the global medical tourism market was dominated by India in the recent past and the trend is expected to continue in the years to come. The medical tourism market in India is predicted to reach US$14,058.1 mn by 2019, followed by Brazil. Asia has become the most prominent markets for medical tourism, with countries such as India, Malaysia, Thailand, and Singapore leading the demand for healthcare services. Cultural similarity and geographic proximity are two of the factors that can be credited for the growth of the medical tourism market in Asia. The rising aging population is a boon for the global medical tourism market. With age, people are facing many health issues. The demand for quality medical care and treatment is increasing in many nations. Some other factors expected to boost the demand for medical tourism are the reduced cost of procedures, large uninsured population, the rising tourism industry, and wider treatment options. An improved healthcare infrastructure is benefiting the players operating in the global medical tourism industry to offer required services. Thanks to improved medical infrastructure, aging people are able to avail medical services while being on a tour. Follow-up Care to be the Biggest Challenge Although the global demand for medical tourism is increasing at a considerable pace, the lack of follow-up care is expected to be the biggest challenge for the key companies operating in the global medical tourism market. “Management of post-treatment complications and post-operation complications are still a problem for the patients,” says TMR analysts. Local healthcare service providers find it uncomfortable to solve complicated medical cases that are performed by unknown medical professionals in various tourist locations. This is another problem expected to restrict the growth of the global medical tourism market. Governments of many nations are supporting medical tourism by increasing their funding for research and development of new drugs. With favorable government policies, medical tourism has been simplified. Medical tourism has gained significant importance in the global tourism market. Governments of countries such as India, Singapore, Thailand, and China have formed separate medical tourism agencies to be a part of the growing global medical tourism market. Many governments are allowing new companies to enter the global medical tourism market, which is expected to propel the market in many ways. This information is based on the findings of a report published by Transparency Market Research titled “Medical Tourism Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019.” Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
News Article | November 25, 2016
The report “Brazil, Russia, India, China (BRIC) Telemedicine Market Delivery Mode (Web-Based, Cloud-based, On-premise), Application (Teleconsultation, Teleradiology, Teledermatology, Telepathology), Component (Services (Store-and-forward), Software (Integrated), Hardware (Monitors)) - Forecast to 2020” provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the BRIC telemedicine market along with the estimates and forecasts of the revenue. Browse more than 45 market data tables with 38 figures spread through 107 pages and in-depth TOC on "Brazil, Russia, India, China (BRIC) Telemedicine Market Delivery Mode (Web-Based, Cloud-based, On-premise), Application (Teleconsultation, Teleradiology, Teledermatology, Telepathology), Component (Services (Store-and-forward), Software (Integrated), Hardware (Monitors)) - Forecast to 2020" http://www.marketsandmarkets.com/Market-Reports/telemedicine-market-237.html Early buyers will receive 10% customization on report. The BRIC telemedicine market is expected to reach USD 1.20 Billion by 2020 from USD 498.7 Million in 2015, growing at a CAGR of 19.2% during the forecast period (2015–2020). The need for better healthcare in rural areas, tremendous growth in telecommunication, rising prevalence of chronic diseases in BRIC nations, and low cost of telemedicine are the major drivers for the BRIC telemedicine market. However, high infrastructural costs and lack of skilled resources may restrain the market growth to a certain extent. On the other hand, favorable government initiatives present a huge growth potential for telemedicine in the BRIC nations. Lack of telemedicine standards in the BRIC countries may however pose a challenge to the growth of this market. In this report, the BRIC telemedicine market is broadly segmented by component, application, delivery mode, and country. On the basis of component, the BRIC telemedicine market is divided into services, software, and hardware. The services segment accounted for the largest share of the BRIC telemedicine market in 2015. Factors such as rising adoption of remote monitoring solutions and technological advancements in telecommunications are contributing to the growth of this segment. On the basis of deployment mode, the BRIC telemedicine system market is categorized into three segments, namely, on-premise, web-based, and cloud-based. The web-based segment accounted for the largest share of the BRIC telemedicine delivery mode market in 2015. Factors such as huge customer base and remote data accessibility are driving the growth of this segment. On the basis of application, the BRIC telemedicine market is segmented into teleconsultation, teleradiology, telecardiology, telepathology, teledermatology, and other applications. The teleconsultation segment accounted for the largest share in 2015. China accounted for more than half of the share of the BRIC telemedicine market in 2015. It is a major market for telemedicine due to factors such as widespread awareness and acceptance of telemedicine, rising incidences of chronic and lifestyle diseases, and growing healthcare expenditure. In addition, major local companies have easy access to this market, which makes it the largest and most significant market for suppliers. Brazil, on the other hand, is expected to grow at the highest CAGR over the next five years. Growth in the Brazilian telemedicine market is mainly driven by the increased purchasing power, emerging mindset towards wellness, and rising healthcare expenditure in the country. Major players in this market include Apollo Hospitals (India), AMD Telemedicine Technologies (U.S.), GE Healthcare (U.K.), Neosoft (China), and SnapMD (U.S.).
Ramalingam K.,Apollo Hospitals |
Monga A.,University of Southampton
Best Practice and Research: Clinical Obstetrics and Gynaecology | Year: 2015
Obesity is associated with a high prevalence of pelvic floor disorders. Patients with obesity present with a range of urinary, bowel and sexual dysfunction problems as well as uterovaginal prolapse. Urinary incontinence, faecal incontinence and sexual dysfunction are more prevalent in patients with obesity. Uterovaginal prolapse is also more common than in the non-obese population. Weight loss by surgical and non-surgical methods plays a major role in the improvement of these symptoms in such patients. The treatment of symptoms leads to an improvement in their quality of life. However, surgical treatment of these symptoms may be accompanied by an increased risk of complications in obese patients. A better understanding of the mechanism of obesity-associated pelvic floor dysfunction is essential. © 2015 Elsevier Ltd. All rights reserved.
Dash S.K.,Apollo Hospitals
Recent Patents on Endocrine, Metabolic and Immune Drug Discovery | Year: 2013
The aim of this manuscript is to provide a brief review of the link between diabetes mellitus with cognitive impairment, the possible pathophysiology linking the two, and some possible therapeutic interventions for the treatment of this condition. The prevalence of diabetes increases with age, so also dementia increases in later life. As the population ages, type 2 diabetes and AD are increasing. Both diseases are chronic and are the leading causes of morbidity and mortality. Recent studies showed that older people with type 2 diabetes have a higher risk of cognitive decline. The precise mechanism linking the two remains to be found out. Several hypothetical mechanisms have been postulated. Type 2 diabetes is a risk factor for AD and vascular dementia. The association between diabetes and AD is particularly strong among carriers of the APOE 4. Several studies have linked dementia to diabetes. Impaired fasting glucose and impaired glucose tolerance and insulin resistance have also been associated with poor cognitive performance and at risk of developing cognitive impairment. Studies have suggested that metabolic syndrome may be linked to vascular dementia, while contrasting findings showed the role of metabolic syndrome to AD. In this review, how diabetes and cognitive impairment and Alzheimer's disease are mutually linked, possible mechanism linking the two and some possible therapeutic interventions with some patents that seem to be good therapeutic targets in future are discussed. © 2013 Bentham Science Publishers.
Shringarpure S.S.,Apollo Hospitals
Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia | Year: 2012
Perivascular epithelioid cell tumors are a family of related mesenchymal neoplasms that include angiomyolipoma, lymphangiomyomatosis, clear cell sugar tumor of the lung and a group of rare morphologically and immunophenotypically similar lesions that show immunoreactivity for both melanocytic (HMB-45 and/or melan-A) and smooth muscle (actin and/or desmin) markers. This case is presented for its rare occurrence and characteristic morphologic and immunohistochemical features.
Ganapathy K.,Apollo Hospitals
World Neurosurgery | Year: 2013
This overview of neurosurgery in India during the last six decades gives a holistic perspective of the phenomenal advances made. Neurosurgical education, the change in clinical spectrum of diseases and their presentation, evolution of various subspecialties and societies, the state of research, the issues peculiar to India, including the urban-rural health divide, the increasing role of information and communication technology in neurosurgery, and the gradual but definite global recognition of Indian neurosurgery will be addressed. © 2013 Elsevier Inc. All rights reserved.
Ganapathy K.,Apollo Hospitals
Neurology India | Year: 2015
Majority of Indians have no access to centres of neurological excellence in the country. A detailed analysis of 3666 members of the Neurological Society of India and the Indian Academy of Neurology revealed that not a single member lived in a geographical area covering 934.8 million people. 30.09% live in the four major metropolitan cities, 29.54% in the state capitals, 30.58% in Tier 2 cities, 7.12% in tier 3 cities and 2.67% in rural areas covering a population of 84.59 million. Building additional neurological centres cannot be the only answer, given the acute shortage of funds and trained personnel. In 1999, the author among others, foresaw that it could be possible, to extend the reach of urban specialists to suburban and rural India, by virtual means. The neurological community has been slow to use Information and Communication Technology (ICT) as an integral part of their health care delivery system. This article analyses the distribution of neurologists and neurosurgeons in India and suggests that providing additional virtual neurological care can be the only answer to offset the lop sided distribution of clinical care givers in neurosciences. In this article, the authors′ considerable experience in introducing and developing telehealth in India over the last 15 years is being shared with specific emphasis on its relevance to neurosciences. A review of the global literature on telemedicine and neurosciences will substantiate the plea that telemedicine must be deployed by neurologists and neurosurgeons in India to extend their reach to patients particularly those residing in rural areas. © 2015, Medical Knowledge. All rights reserved.